Ayala Pharmaceuticals Valuation
| ADXSDelisted Stock | USD 0.62 0.03 4.62% |
Ayala Pharmaceuticals is overvalued. Ayala Pharmaceuticals shows a prevailing Real Value of $0.59 per share. The current price of the firm is $0.62. Our model approximates the value of Ayala Pharmaceuticals from analyzing the firm fundamentals such as current valuation of (25.1 M), and Return On Equity of -41.98 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Ayala Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Ayala Pharmaceuticals is based on 3 months time horizon. Increasing Ayala Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Ayala Pharmaceuticals is useful when determining the fair value of the Ayala otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Ayala Pharmaceuticals. Since Ayala Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ayala OTC Stock. However, Ayala Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.62 | Real 0.59 | Hype 0.62 |
The real value of Ayala OTC Stock, also known as its intrinsic value, is the underlying worth of Ayala Pharmaceuticals OTC Stock, which is reflected in its stock price. It is based on Ayala Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Ayala Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ayala Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ayala Pharmaceuticals helps investors to forecast how Ayala otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ayala Pharmaceuticals more accurately as focusing exclusively on Ayala Pharmaceuticals' fundamentals will not take into account other important factors: Ayala Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Ayala Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Ayala Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ayala Pharmaceuticals competition to find correlations between indicators driving Ayala Pharmaceuticals's intrinsic value. More Info.Ayala Pharmaceuticals is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Ayala Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ayala Pharmaceuticals' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ayala Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ayala Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ayala Pharmaceuticals and how it compares across the competition.
About Ayala Pharmaceuticals Valuation
The otc valuation mechanism determines the current worth of Ayala Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Ayala Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Ayala Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Ayala Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Ayala Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ayala Pharmaceuticals. We calculate exposure to Ayala Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ayala Pharmaceuticals's related companies.Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes technology antigen delivery products in the United States. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey. Advaxis operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 14 people.
8 Steps to conduct Ayala Pharmaceuticals' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Ayala Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ayala Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ayala Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ayala Pharmaceuticals' revenue streams: Identify Ayala Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ayala Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ayala Pharmaceuticals' growth potential: Evaluate Ayala Pharmaceuticals' management, business model, and growth potential.
- Determine Ayala Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ayala Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Ayala Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Ayala Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Shares Percent Shares Out | 2.19% | |
| Forward Price Earnings | -10.00 | |
| Float Shares | 1.82M | |
| Shares Short Prior Month | 44.99k |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Ayala OTC Stock
If you are still planning to invest in Ayala Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ayala Pharmaceuticals' history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |